Redcare Pharmacy NV
Redcare Pharmacy NV operates the online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It offers prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. Redcare P… Read more
Redcare Pharmacy NV (RDC) - Total Liabilities
Latest total liabilities as of December 2025: €767.30 Million EUR
Based on the latest financial reports, Redcare Pharmacy NV (RDC) has total liabilities worth €767.30 Million EUR as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Redcare Pharmacy NV - Total Liabilities Trend (2013–2025)
This chart illustrates how Redcare Pharmacy NV's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Redcare Pharmacy NV Competitors by Total Liabilities
The table below lists competitors of Redcare Pharmacy NV ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Lexinfintech Holdings Ltd
NASDAQ:LX
|
USA | $11.24 Billion |
|
Jiangsu Province Commun
SHG:603018
|
China | CN¥7.03 Billion |
|
Etablissements Maurel et Prom SA
PA:MAU
|
France | €806.82 Million |
|
Changyuan Group Ltd
SHG:600525
|
China | CN¥10.67 Billion |
|
BioAge Labs, Inc
NASDAQ:BIOA
|
USA | $27.63 Million |
|
Utz Brands Inc
NYSE:UTZ
|
USA | $1.41 Billion |
|
Compass Therapeutics Inc.
NASDAQ:CMPX
|
USA | $21.65 Million |
|
Tokyo Steel Manufacturing Co., Ltd.
PINK:TOKSF
|
USA | $80.46 Billion |
Liability Composition Analysis (2013–2025)
This chart breaks down Redcare Pharmacy NV's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.55 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.67 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.62 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Redcare Pharmacy NV's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Redcare Pharmacy NV (2013–2025)
The table below shows the annual total liabilities of Redcare Pharmacy NV from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €767.30 Million | +55.54% |
| 2024-12-31 | €493.31 Million | +5.06% |
| 2023-12-31 | €469.56 Million | +25.27% |
| 2022-12-31 | €374.84 Million | +1.95% |
| 2021-12-31 | €367.66 Million | +228.94% |
| 2020-12-31 | €111.77 Million | -42.74% |
| 2019-12-31 | €195.22 Million | +42.57% |
| 2018-12-31 | €136.93 Million | +132.70% |
| 2017-12-31 | €58.84 Million | +117.08% |
| 2016-12-31 | €27.11 Million | -32.76% |
| 2015-12-31 | €40.31 Million | +326.46% |
| 2014-12-31 | €9.45 Million | +23.71% |
| 2013-12-31 | €7.64 Million | -- |